Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,970 public trials 3,764 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NCT07166094

Conditions
Disease Attributes, Endometrial Cancer, Endometrial Neoplasms, +15 more
Locations
  • HonorHealth Research Inst Phoenix, Arizona, United States
  • Kaiser Permanente SoCal Irvine, California, United States
  • MedStar Washington Hospital Washington D.C., District of Columbia, United States
  • SMH - Sarasota - Main Campus Sarasota, Florida, United States
View all 171 locations
View Trial Details
Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

NCT06890338

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
  • Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
  • University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
View all 70 locations
View Trial Details
Recruiting

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

NCT03549754

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease, +22 more
Locations
  • Research Site Fortaleza, Ceará, Brazil
  • Research Site Colatina, Espírito Santo (ES), Brazil
  • Research Site Salvador, Estado de Bahia, Brazil
  • Research Site Brasília, Federal District, Brazil
View all 76 locations
View Trial Details
Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Stanford Palo Alto, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal
View Trial Details
Recruiting

An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China

NCT07604766

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Chongqing University Cancer Hospital - Chongqing Cancer Hospital Chongqing, China
  • Fudan University Shanghai Cancer Hospital Shanghai, China
  • Obstetrics & Gynecology Hospital of Fudan University Shanghai, China
  • Tianjin Medical University Cancer Institute & Hospital Tianjin, China
View all 17 locations
View Trial Details
Recruiting

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

NCT05657990

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +4 more
Locations
  • Ocean University Medical Center Brick, New Jersey, United States
  • South Ocean University Medical Center Manahawkin, New Jersey, United States
  • Jersey Shore University Medical Center Neptune City, New Jersey, United States
  • Riverview Medical Center Red Bank, New Jersey, United States
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

NCT07225270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Mt. Sinai Comprehensive Cancer Center Miami, Florida, United States
  • Sarasota Memorial Health Care System Sarasota, Florida, United States
  • Miami Valley Hospital South Centerville, Ohio, United States
  • Zangmeister Cancer Center Columbus, Ohio, United States
View all 22 locations
View Trial Details
Recruiting

PS-002 for the Treatment of IgA Nephropathy in Adults

NCT07182227

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • University of Miami Hospital Miami, Florida, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Manchester University NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
View Trial Details
Recruiting

Keeping RAASi Treatment With Optimal Potassium Control

NCT06578533

Conditions
Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +10 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital Universitario Vall d'Hebrón Barcelona, Spain
  • Hospital Universitario 12 de Octubre Madrid, Spain
  • Hospital Clínico Universitario de Valencia Valencia, Spain
View Trial Details

Related conditions